Archives: Speakers

Collaborative and outcome-based biopharmaceutical servant-leader providing 20+ years of clinical operations experience. Passionately advancing the mission of improving patients’ lives through timely and efficient execution of clinical trials. Adept at building and managing cross-functional teams comprising internal and/or external partners and CROs to meet the dynamic business needs of virtual start-ups to leading life science companies.

Arla holds an MSc in Interdisciplinary Oncology and is both CCRP and PMP certified. She has worked in healthcare and oncology for over 15 years, with the last 9 years spent focused on clinical research operations at UCSF’s NCI-designated Comprehensive Cancer Center.

Chief Medical Officer at ASC Therapeutics, a biopharma company focusing on gene editing and gene therapy for Hemophilia A and MSUD, and allogeneic cell therapy for Graft-vs-Host Disease in hematologic malignancies. Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain
Author and co-author of over 100 peer-reviewed publications, including Nature, Lancet, Journal of Immunology and Journal of Experimental Medicine, books and medical articles and member of several scientific and medical societies.

Kateryna is an Associate Director, Clinical Quality Management Lead at MSD Ukraine responsible for quality management in trials conducted in Ukraine, Georgia and Moldova. She holds over 15 years of expertise in different roles in clinical trials including 7 years in quality management at MSD.

She is responsible for variety of duties in process management, quality control and compliance, risk assessment – altogether to ensure business continuity for the conducted studies.

Kateryna holds BSc in Economic Theory, MA in Health Care Management obtained from Kyiv-Mohyla Academy (Ukraine) and Maastricht University (Netherlands), and has a post-graduate degree in Pharmacy from National Medical University of Bogomolets (Ukraine).

Nicolas has extensive experience in management consulting for the banking industry as well as in financing softwares. He has been Pre-Sales Director, Program Director and Product Marketing Director for wholesale finance, credit and leasing activities in Europe and Asia. He is a graduate engineer from the Ecole Centrale de Lyon and a graduate of ESSEC.

Nick has worked in the asset finance industry for over 20 years, specialising in providing bespoke insurance products for equipment lessors. As CEO of Acquis, Nick works in partnership with some of the largest lessors in Europe and has witnessed first-hand the resilience the asset finance industry has shown in rising to overcome the major challenges of the past two decades, such as the 2007/8 banking crisis and the Covid-19 pandemic. Nick believes the transition towards sustainability is one of the greatest challenges the industry has faced, but is confident that the asset finance industry is very well placed to achieve its sustainability agenda and lead the financial services industry in making a positive environmental impact for the benefit of future generations.